HIV逆転写酵素阻害剤として有用な4,4―二置換―1,4―ジヒドロ―2H―3,1―ベンゾオキサジン―2―オン類、およびそれらを製造するための中間体および方法

Title:

Document Type and Number:

Japanese Patent JP4212650

Kind Code:

B2

Abstract:

The present invention relates to benzoxazinones of formula I, or stereoisomeric forms or mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, methods of using same for treating viral infection or as an assay standard or reagent, and intermediates and processes for making the same.

More Like This:

JP4533391	1-benzyl-5-Piperazine-1-yl-3,4-dihydro-1H-quinazoline-2-one derivative as a modulator of 5-hydroxytryptamine receptor (5-HT) for the treatment of central nervous system disorders , And their respective 1H-benzo (1,2,6) thiadiadin-2,2-dioxide and 1,4-dihydrobenzo (D) (1,3) oxazine-2-one derivatives.
WO/2009/004430	N-BENZYL OXAZOLIDINONES AND RELATED HETEROCYCLEIC COMPOUNDS AS POTENTIATORS OF GLUTAMATE RECEPTORS
WO/2003/000323	SAFETY SHIELD SYSTEM FOR PREFILLED SYRINGES

Inventors:

Christ, David, Donald.
Mark Walder, Jay, Andrew.
Fortunac, Joseph, Marian.
Kor, Sue, Sun.
Matrib, Abdal, Ezzaz.
Parsons, Rodney, Lawrence, Junior.
Patel, Mona.
Sights, Stephen, Paul.
Kokuzza, Anthony, Joseph.

Application Number:

JP51677598A

Publication Date:

January 21, 2009

Filing Date:

October 01, 1997

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Bristol-Myers Squibb Pharma Company

International Classes:

C07D265/18; A61K31/535; A61K31/536; A61K31/5365; A61P31/18; A61P37/04; A61P43/00; C07B59/00; C07C213/00; C07D213/75; C07D265/24; C07D339/08; C07D413/04; C07D413/06; C07D413/14; C07D417/06; C07D498/04

Domestic Patent References:

JP6184124A

Foreign References:

US3526621

Attorney, Agent or Firm:

Yoshikazu Tani
Kazuo Abe

Previous Patent: 酸化銅還元方法

Next Patent: AIR BAG TYPE RIDER PROTECTOR